Clinical trial

Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study

NCT01469169

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-06-19

PhasePHASE3

Study timeline

Study start (actual)2012-06-19Date precision: day

Registry last updated2017-12-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension, Pulmonaryunresolved

Interventions

Iloprost (Ventavis inhaled, BAYQ6256)DRUG

Sponsors & collaborators

Bayerlead sponsor

Mapped research locations

NagoyaAichi-ken, Japan2 ChibaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01469169 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.